Paradigm Biopharmaceuticals Limited (PAR.AX)
AUD 0.37
(-2.67%)
AUD 0.37
(-2.67%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 239.33 Thousand AUD | -29.95% |
| 2023 | 341.66 Thousand AUD | -44.6% |
| 2022 | 616.66 Thousand AUD | -17.98% |
| 2021 | 751.84 Thousand AUD | -13.95% |
| 2020 | 873.68 Thousand AUD | 2287.85% |
| 2019 | 36.58 Thousand AUD | 0.0% |
| 2018 | 36.58 Thousand AUD | 0.0% |
| 2017 | 36.58 Thousand AUD | 0.0% |
| 2016 | 36.58 Thousand AUD | -78.7% |
| 2015 | 171.78 Thousand AUD | -12.26% |
| 2014 | 195.78 Thousand AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 290.31 Thousand AUD | 0.0% |
| 2024 FY | 239.33 Thousand AUD | -29.95% |
| 2024 Q4 | 239.33 Thousand AUD | 0.0% |
| 2023 FY | 341.66 Thousand AUD | -44.6% |
| 2023 Q4 | 341.66 Thousand AUD | 0.0% |
| 2023 Q2 | 389.78 Thousand AUD | 0.0% |
| 2022 Q4 | 616.66 Thousand AUD | 0.0% |
| 2022 Q2 | 594.66 Thousand AUD | 0.0% |
| 2022 FY | 616.66 Thousand AUD | -17.98% |
| 2021 FY | 751.84 Thousand AUD | -13.95% |
| 2021 Q4 | 751.84 Thousand AUD | 0.0% |
| 2021 Q2 | 814.24 Thousand AUD | 0.0% |
| 2020 Q4 | 873.68 Thousand AUD | 0.0% |
| 2020 FY | 873.68 Thousand AUD | 2287.85% |
| 2020 Q2 | 930.26 Thousand AUD | 0.0% |
| 2019 Q4 | 36.58 Thousand AUD | 0.0% |
| 2019 FY | 36.58 Thousand AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2018 FY | 36.58 Thousand AUD | 0.0% |
| 2018 Q4 | 36.58 Thousand AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 Q4 | 36.58 Thousand AUD | 0.0% |
| 2017 FY | 36.58 Thousand AUD | 0.0% |
| 2016 Q2 | 36.63 Thousand AUD | 0.0% |
| 2016 Q4 | 36.58 Thousand AUD | 0.0% |
| 2016 FY | 36.58 Thousand AUD | -78.7% |
| 2015 Q4 | 171.78 Thousand AUD | 0.0% |
| 2015 FY | 171.78 Thousand AUD | -12.26% |
| 2014 FY | 195.78 Thousand AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 123.85 Thousand AUD | -93.232% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Zelira Therapeutics Limited | 5.65 Million AUD | 95.767% |
| Biome Australia Limited | 1.3 Million AUD | 81.671% |
| Patrys Limited | - AUD | -Infinity% |
| Orthocell Limited | 689.69 Thousand AUD | 65.299% |
| Imugene Limited | 1.54 Million AUD | 84.529% |
| Noxopharm Limited | - AUD | -Infinity% |
| PYC Therapeutics Limited | 1.11 Million AUD | 78.493% |
| Chimeric Therapeutics Limited | - AUD | -Infinity% |
| Prescient Therapeutics Limited | 330.48 Thousand AUD | 27.582% |
| Proteomics International Laboratories Limited | 316.39 Thousand AUD | 24.357% |
| Cynata Therapeutics Limited | - AUD | -Infinity% |
| CSL Limited | 18.24 Billion AUD | 99.999% |
| Arovella Therapeutics Limited | - AUD | -Infinity% |
| Bio-Gene Technology Limited | - AUD | -Infinity% |
| Clinuvel Pharmaceuticals Limited | 879.78 Thousand AUD | 72.797% |
| Starpharma Holdings Limited | 3.52 Million AUD | 93.216% |
| Nanollose Limited | 42.53 Thousand AUD | -462.732% |
| Memphasys Limited | 4.41 Million AUD | 94.577% |
| Invex Therapeutics Ltd | - AUD | -Infinity% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | 1.56 Million AUD | 84.675% |
| Botanix Pharmaceuticals Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | 421.96 Thousand AUD | 43.282% |
| Race Oncology Limited | - AUD | -Infinity% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 17.44 Million AUD | 98.628% |
| Dimerix Limited | 149.68 Thousand AUD | -59.891% |
| PharmAust Limited | - AUD | -Infinity% |
| Immutep Limited | 1.22 Million AUD | 80.515% |
| Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 159.04 Thousand AUD | -50.479% |
| BTC Health Limited | - AUD | -Infinity% |
| Acrux Limited | 1.48 Million AUD | 83.905% |
| Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
| Biotron Limited | 7130.00 AUD | -3256.662% |
| Tissue Repair Ltd | - AUD | -Infinity% |
| AdAlta Limited | 2.49 Million AUD | 90.406% |
| Radiopharm Theranostics Limited | - AUD | -Infinity% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 23.59 Thousand AUD | -914.454% |
| Recce Pharmaceuticals Ltd | 811.19 Thousand AUD | 70.496% |
| Avecho Biotechnology Limited | 175.15 Thousand AUD | -36.642% |
| Actinogen Medical Limited | 319.06 Thousand AUD | 24.991% |
| Immuron Limited | 173.49 Thousand AUD | -37.945% |
| Argenica Therapeutics Limited | - AUD | -Infinity% |